Neurodevelopmental Disorder

Children of women prescribed antiseizure medications for epilepsy during pregnancy did not have worse neurodevelopmental outcomes by age 6 compared with children of women who did not receive them, according to new research.

Women who sleep less than 7 hours per night during pregnancy may be more likely to have a boy with neurodevelopmental delays, according to data published in The Journal of Clinical Endocrinology & Metabolism.

Metformin exposure during pregnancy was not associated with adverse childhood neurodevelopmental outcomes up to age 14 years, according to a systematic review and meta-analysis published in the American Journal of Obstetrics and Gynecology.

Hypoglycemia was not associated with later neurodevelopmental outcomes for children born late preterm, according to findings presented at The Pregnancy Meeting.

In utero exposure to amphetamine/dextroamphetamine or methylphenidate was not associated with increased risks for neurodevelopmental disorders in children, according to cohort study results published in JAMA Psychiatry.

CHICAGO — Environmental chemical exposure is a risk factor for neurodegenerative diseases and neurodevelopmental disorders, an expert at the 2022 American Neurological Association annual meeting said.

The presence of neurodevelopmental or mental disorders or self-harm before age 24 years increased risk for missing school, according to results of a nationwide, retrospective, electronic cohort study.

Cannabis use in middle to late adolescence may alter neurodevelopment, according to study results published in JAMA Psychiatry.

Children whose mothers used cannabis during pregnancy are at a higher risk for autism compared with children whose mothers did not, according to a study published in Nature Medicine.

Preeclampsia in term pregnancies appeared to have lasting effects on the neurodevelopment of the child, according to results of a prospective, population-based cohort study published in JAMA Psychiatry.